Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Los Angeles, CALIFORNIA, Feb. 26, 2026 (GLOBE NEWSWIRE) -- HelpAlert, an elderly welfare monitoring platform developed by Australian innovators Mike and Darren Steele, today announced the official...
-
Dublin, Feb. 26, 2026 (GLOBE NEWSWIRE) -- The "Subsea Reconfigurable Optical Add-Drop Multiplexer (ROADM) Market Report 2026" report has been added to ResearchAndMarkets.com's offering.The subsea...
-
Ottawa, Feb. 25, 2026 (GLOBE NEWSWIRE) -- According to Precedence Research, the global type 2 diabetes market size is predicted to reach around USD 79.25 billion by 2035, increasing from USD 43.29...
-
Cleanliness On-the-Go: The Honest Company’s best-selling Fragrance Free Sanitizing Wipes are now available in Lavender and Grapefruit scents and travel‑friendly pack sizes.Trusted, Clean Conscious™...
-
Dublin, Feb. 23, 2026 (GLOBE NEWSWIRE) -- The "Condom Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global condom market is experiencing remarkable growth,...
-
Austin, United States, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Vaginitis Therapeutics Market Size & Growth Analysis: According to SNS Insider, The Vaginitis Therapeutics Market size was valued at...
-
Dublin, Feb. 19, 2026 (GLOBE NEWSWIRE) -- The "Pipeline of Claudin 18.2-Targeted Immunotherapy" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report about...
-
Dublin, Feb. 18, 2026 (GLOBE NEWSWIRE) -- The "Monoclonal Antibodies - Competitive Landscape, 2026" has been added to ResearchAndMarkets.com's offering. The report offers a detailed analysis...
-
SAN MATEO, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Nexla, the enterprise-grade AI-powered data integration platform for agents, today announced a strategic partnership with Vespa.ai, the creator...
-
Stenoparib is being evaluated in combination with temozolomide clinical benefit in relapsed Small Cell Lung CancerTrial is fully funded by the U.S. Department of Veterans Affairs and is open for...